MedTrace Logo

Preoperative Single-dose Steroid Application for the Treatment of Nausea and Vomiting After Thyroid Surgery

NCT01189292 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2015-07-07

Study results available
· View outcomes & findings →

Summary

The study is to compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy.

Conditions

  • Thyroidectomy
  • Thyroid Diseases

Interventions

DRUG

Dexamethasone

8mg (2ml) of dexamethasone (Mephameson®) administered intravenously preoperatively before thyroid surgery

OTHER

NaCl 0.9%

2ml of NaCl 0.9% administered intravenously preoperatively before thyroid surgery

Sponsors & Collaborators

  • Cantonal Hospital of St. Gallen

    lead OTHER

Principal Investigators

  • Thomas Clerici, MD · Cantonal Hospital St. Gallen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-05-31
Completion
2013-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01189292 on ClinicalTrials.gov